Transplantation of autologous bone marrow mononuclear cells with VEGF gene improves diabetic critical limb ischaemia

Endokrynologia Polska

Volumn 64, Issue 2, 2013, Pages 129-138

  Skóra, Jan ^a   Barć, Piotr ^a   Pupka, Artur ^a   Dawiskiba, Tomasz ^a   Korta, Krzysztof ^a   Albert, Michael ^a   Szyber, Piotr ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Bone marrow mononuclear cells; Diabetic foot; Gene therapy; VEGF

Indexed keywords

INSULIN; PLASMID DNA; RECOMBINANT VASCULOTROPIN;

ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW BIOPSY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; FOOT ULCER; HUMAN; INSULIN TREATMENT; LEG AMPUTATION; LEG ULCER; MALE; PATIENT SAFETY; THERAPY EFFECT; VISUAL ANALOG SCALE; WOUND DRESSING; WOUND INFECTION;

AGED; BONE MARROW; BONE MARROW TRANSPLANTATION; DIABETES MELLITUS; DIABETIC FOOT; FEMALE; GENETIC THERAPY; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; MIDDLE AGED; PAIN MEASUREMENT; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878123752     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Weck M, Slesaczeck T, Rietzsch H et al. Noninvasive management of the diabetic foot with critical limb ischemia: current options and future perspectives. Ther Adv Endocrinol Metab 2011; 2: 247-55.
2. Prompers L, Huijberts M, Apelqvist J et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50: 18-25. (Pubitemid 46035847)
3. Wang L, Zhao S, Mao H et al. Autologous bone marrow stem cell transplantation for the treatment of type 2 diabetes mellitus. Chin Med J (Engl) 2011; 124: 3622-8.
4. Kügler CF, Rudofsky G. The challenges of treating peripheral arterial disease. Vasc Med 2003; 8: 109-114. (Pubitemid 37168252)
5. Eckardt A, Kraus O, Küstner E et al. Interdisciplinary treatment of diabetic foot syndrome. Orthopade 2003; 32: 190-198. (Pubitemid 36622349)
6. Loomans CJ, de Koning EJ, Staal FJ et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195-199. (Pubitemid 38044715)
7. Tepper OM, Galiano RD, Capla JM et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-2786. (Pubitemid 35396976)
8. Lechner A, Habener JF. Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am J Physiol Endocrinol Metab 2003; 284: E259-266. (Pubitemid 36120097)
9. Eskelinen E, Eskelinen A, Albäck A et al. Major amputation incidence decreases both in non-diabetic and in diabetic patients in Helsinki. Scand J Surg 2006; 95: 185-189. (Pubitemid 44476538)
10. Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007; 33 (Suppl. 1): S1-75.
11. Schatteman GC, Hanlon HD, Jiao C et al. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000; 106: 571-578. (Pubitemid 30666390)
12. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438. (Pubitemid 29180584)
13. Al-Khaldi A, Al-Sabti H, Galipeau J et al. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 2003; 75: 204-209. (Pubitemid 36099048)
14. Iwaguro H, Yamaguchi J, Kalka C et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002; 105: 732-738. (Pubitemid 34157378)
15. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435.
16. Kurpisz M, Czepczyński R, Grygielska B et al. Bone marrow stem cell imaging after intracoronary administration. Int J Cardiol 2007; 121: 194-195. (Pubitemid 47381321)
17. Shyu KG, Chang H, Wang BW et al. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am J Med 2003; 114: 85-92. (Pubitemid 36183588)
18. Kusumanto YH, van Weel V, Mulder NH et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther 2006; 17: 683-691. (Pubitemid 43970708)
19. Hedman M, Hartikainen J, Syvänne M et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677-2683. (Pubitemid 36667240)
20. Isner JM, Pieczek A, Schainfeld R et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996; 348: 370-374. (Pubitemid 26261511)
21. Isner JM. Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results. Adv Drug Deliv Rev 1998; 30: 185-197. (Pubitemid 28201913)
22. Miyamoto K, Nishigami K, Nagaya N et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 2006; 114: 2679-2684. (Pubitemid 44967352)
23. Isner JM, Baumgartner I, Rauh G et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 1998; 28: 964-973.
24. Skóra J, Sadakierska-Chudy A, Pupka A et al. Application of VEGF165 plasmid in treatment of critical lower limb ischemia. Pol Merkur Lekarski 2006; 20: 655-659. (Pubitemid 44084953)
25. Stewart DJ, Hilton JD, Arnold JM et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther 2006; 13: 1503-1511. (Pubitemid 44574158)
26. Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422-3427. (Pubitemid 30183318)
27. Yamamoto K, Kondo T, Suzuki S et al. Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler Thromb Vasc Biol 2004; 24: 192-196.
28. Sadakierska - Chudy A, Baczyńska D, Skóra J et al. Transfection efficiency and cytotoxicity of transfection reagents in human umbilical vein endothelial cells. Adv Clin Exp Med 2008; 17: 625-634.
29. Choksy S, Pockley AG, Wajeh YE et al. VEGF and VEGF receptor expression in human chronic critical limb ischaemia. Eur J Vasc Endovasc Surg 2004; 28: 660-669. (Pubitemid 39462661)
30. Rutherford RB, Becker GJ. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. Radiology 1991; 181: 277-281.
31. Takeshita S, Isshiki T, Mori H et al. Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia. Circulation 1997; 95: 805-808. (Pubitemid 27091517)